Review Article

CME Article: Fat Embolism Syndrome Secondary to Bone Marrow Necrosis in Patients with Hemoglobinopathies

Authors: Radhika Gangaraju, MD, Vishnu V.B. Reddy, MD, Marisa B. Marques, MD

Abstract

Bone marrow necrosis with subsequent embolization of the fat and necrotic tissues into the systemic circulation causing fat embolism syndrome and multiorgan failure is a rare complication of patients with hemoglobinopathies. The exact etiology of this condition is not known. Because it occurs more often in patients with compound heterozygous conditions than in sickle cell disease, some patients are unaware of their predisposition. The initial symptoms are nonspecific, such as back and/or abdominal pain, fever, and fatigue, which may rapidly progress to respiratory failure and severe neurologic compromise. Common laboratory tests reveal anemia without reticulocytosis, thrombocytopenia, leukoerythroblastic picture with immature white cells and nucleated red blood cells, increased lactate dehydrogenase, high ferritin, and, sometimes increased creatinine. The diagnosis can be delayed because of an apparent lack of awareness about bone marrow necrosis with fat embolism syndrome, its rarity, and its similarities with other conditions such as thrombotic thrombocytopenic purpura. Although a bone marrow biopsy is diagnostic, waiting for it delays definitive treatment, which appears to be essential for the recovery of end-organ damage, such as neurologic and pulmonary damage. In our experience, either multiple units of red blood cell transfusion or, preferably, red cell exchange initiated promptly, is lifesaving.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Stein PD, Yaekoub AY, Matta F, et al. Fat embolism syndrome. Am J Med Sci 2008;336:472-477.
 
2. Kellogg RG, Fontes RBV, Lopes DK. Massive cerebral involvement in fat embolism syndrome and intracranial pressure management. J Neurosurg 2013;119:1263-1270.
 
3. Janssens AM, Offner FC, Van Hove WZ. Bone marrow necrosis. Cancer 2000;88:1769-1780.
 
4. Wool GD, Deucher A. Bone marrow necrosis: ten-year retrospective review of bone marrow biopsy specimens. Am J Clin Pathol 2015;143:201-213.
 
5. Kim SK, Miller JH. Natural history and distribution of bone and bone marrow infarction in sickle hemoglobinopathies. J Nucl Med 2002;43:896-900.
 
6. Hutchinson RM, Merrick MV, White JM. Fat embolism in sickle cell disease. J Clin Pathol 1973;26:620-622.
 
7. Tsitsikas DA, Gallinella G, Patel S, et al. Bone marrow necrosis and fat embolism syndrome in sickle cell disease: increased susceptibility of patients with non-SS genotypes and a possible association with human parvovirus B19 infection. Blood Rev 2014;28:23-30.
 
8. Tzioupis CC, Giannoudis PV. Fat embolism syndrome: what have we learned over the years? Trauma 2011;13:259-281.
 
9. Lee SC, Yoon JY, Nam CH, et al. Cerebral fat embolism syndrome after simultaneous bilateral total knee arthroplasty: a case series. J Arthroplasty 2012;27:409-414.
 
10. Parizel PM, Demey HE, Veeckmans G, et al. Early diagnosis of cerebral fat embolism syndrome by diffusion-weighted MRI (starfield pattern). Stroke 2001;32:2942-2944.
 
11. Adamski A, Hanna CA, Reddy VB, et al. Multiorgan failure and bone marrow necrosis in three adults with sickle cell-β + -thalassemia. Am J Hematol 2012;87:621-624.
 
12. Maisel D, Lim JY, Pollock WJ, et al. Bone marrow necrosis: an entity often overlooked. Ann Clin Lab Sci 1988;18:109-115.
 
13. Charache S, Conley CL. Rate of sickling of red cells during deoxygenation of blood from persons with various sickling disorders. Blood 1964;24:25-48.
 
14. Fabian TC. Unravelling the fat embolism syndrome. N Engl J Med 1993;329:961-963.
 
15. Styles LA, Schalkwijk CG, Aarsman AJ, et al. Phospholipase A2 levels in acute chest syndrome of sickle cell disease. Blood 1996;87:2573-2578.
 
16. Baker PL, Pazell JA, Peltier LF. Free fatty acids, catecholamines, and arterial hypoxia in patients with fat embolism. J Trauma 1971;11:1026-1030.
 
17. Dang NC, Johnson C, Eslami-Farsani M, et al. Bone marrow embolism in sickle cell disease: a review. Am J Hematol 2005;79:61-67.
 
18. Vichinsky E, Williams R, Das M, et al. Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia. Blood 1994;83:3107-3112.
 
19. Herway ST, Slotto J, Harlan E, et al. Cerebral fat embolism syndrome. Anesthesiology 2016;124:1167.
 
20. Graff DM, Owen E, Bendon R, et al. Distinctive acellular lipid emboli in hemoglobin SC disease following bone marrow infarction with parvovirus infection. Case Rep Hematol 2015;2015:328065.
 
21. Hassell KL, Eckman JR, Lane PA. Acute multiorgan failure syndrome: a potentially catastrophic complication of severe sickle cell pain episodes. Am J Med 1994;96:155-162.
 
22. Schwartz J, Padmanabhan A, Aqui N, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the seventh special issue. J Clin Apher 2016;31:163-338.